LH vs RNAZ · P/E 23, rev $7.27B vs $5.1M cap
Laboratory Corporation of America Holdings (LH) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
RNAZ does not have a complete income-statement cache yet.
LH currently screens at market cap $21.07B and trailing P/E 22.8. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the LH and RNAZ stock pages for the full models.
Not investment advice.